民生证券股份有限公司 关于深圳市优优绿能股份有限公司 使用募集资金置换已支付发行费用的自筹资金的核查意见 民生证券股份有限公司（以下简称"民生证券""保荐机构"）作为深圳市优 优绿能股份有限公司（以下简称"优优绿能""公司"）首次公开发行股票并在创 业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司募集资 金监管规则》《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规 范运作》以及《深圳证券交易所上市公司自律监管指引第13号——保荐业务》等有 关法律法规和规范性文件的要求，对优优绿能使用募集资金置换已支付发行费用的 自筹资金进行了审慎核查，并发表如下意见： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意深圳市优优绿能股份有限公司首次公开 发行股票注册的批复》（证监许可〔2025〕466号）同意注册，公司首次公开发行人 民币普通股（A股）股票1,050万股，募集资金总额为人民币940,800,000.00元，扣 减不含税发行费用，实际募集资金净额人民币843,791,385.19元。致同会计师事务 所（特殊普通合伙）对公司首次公开发行股票的资金到账情况进行了审验确认，并 出 ...

东方证券股份有限公司 东方证券股份有限公司（以下简称"东方证券"、"保荐机构"）作为深圳光大 同创新材料股份有限公司（以下简称"光大同创"、"公司"）首次公开发行股票并 在创业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券 交易所创业板股票上市规则》《上市公司募集资金监管规则》及《深圳证券交易 所上市公司自律监管指引第 13 号——保荐业务》等有关规定，对光大同创拟使 用自有资金支付募投项目人员费用并以募集资金等额置换事项进行了审慎核查， 并发表独立意见如下： 一、募集资金基本情况 公司首次公开发行股票已经中国证券监督管理委员会"证监许可〔2023〕361 号"文同意注册，公司公开发行人民币普通股（A 股）股票 19,000,000 股，发行 价格为 58.32 元/股，募集资金总额为人民币 1,108,080,000.00 元，扣除发行费用 （ 不 含 增 值 税 ） 人 民 币 103,717,534.12 元 后 ， 募 集 资 金 净 额 为 人 民 币 金到账情况进行了审验，并于 2023 年 4 月 13 日出具了[2023]3138 号《验资报告》。 关于深圳光大同创新材料股份 ...

Group 1 - The core viewpoint of the article is that the company, Si Rui Pu Microelectronics Technology (Suzhou) Co., Ltd., is using raised funds to replace self-raised funds that were used to pay for a cash consideration in a transaction [1][2][5] - The company plans to purchase 100% equity of Shenzhen Chuangxin Microelectronics Co., Ltd. through the issuance of convertible bonds and cash payments, with a total fundraising amount of RMB 383,379,903.00 [2][4] - The company has pre-paid a cash consideration of RMB 676,610,500.00 using self-raised funds, and intends to replace RMB 361,870,469.04 of this amount with the raised funds [4][5] Group 2 - The company has established a special account for the raised funds and signed a regulatory agreement with the independent financial advisor and the supervising bank [2][4] - The independent financial advisor has confirmed that the use of raised funds to replace pre-paid cash consideration complies with relevant regulations and does not harm shareholder interests [6][7] - The board of directors and the supervisory board have approved the proposal to use raised funds for this purpose, ensuring that the process followed necessary review procedures [6][7]

Core Viewpoint - The company plans to use its own funds to pay for part of the fundraising project expenses and subsequently replace these with equivalent amounts from the raised funds, which is deemed to enhance operational efficiency and ensure the smooth progress of the fundraising projects [1][6][7]. Fundraising Overview - The company has received approval from the China Securities Regulatory Commission to issue 30.8 million A-shares at a price of RMB 31.33 per share, raising a total of RMB 964.96 million. After deducting issuance costs of RMB 86.84 million, the net amount raised is RMB 878.12 million [1]. - As of June 30, 2025, the company has utilized RMB 441.25 million of the raised funds, with RMB 107.00 million directly invested in fundraising projects [4]. Fundraising Project Details - The company has postponed the completion date for several fundraising projects from January 25, 2025, to January 25, 2027, and added its wholly-owned subsidiary, Sichuan Junyi Su Lian Technology Co., Ltd., as a co-implementing entity for these projects [2][3]. - The total investment for the underground comprehensive pipeline smart management operation platform upgrade project and the new smart city comprehensive solution enhancement project is RMB 321.04 million [2]. Reasons for Using Own Funds - The company needs to pay for labor costs, including salaries and social insurance, which cannot be directly paid from the fundraising account as per regulations. Therefore, it plans to use its own funds initially and later replace them with raised funds [5][6]. Operational Process for Fund Replacement - The company will follow a specific payment process where the finance department will pay the relevant project expenses using its own funds and subsequently transfer equivalent amounts from the fundraising account to its own account within six months [6][7]. Impact on the Company - The decision to use its own funds for project expenses is expected to improve operational management efficiency and ensure the smooth implementation of fundraising projects, complying with relevant regulations [6][7]. Review and Opinions - The board of directors and the supervisory board have approved the plan, confirming that it follows necessary procedures and does not affect the normal execution of fundraising projects or harm shareholder interests [7][9]. - The sponsor, Huayin Securities, has also expressed no objections to the plan, affirming its compliance with regulations [9].

证券代码：688163 证券简称：赛伦生物 公告编号：2025-021 上海赛伦生物技术股份有限公司 关于使用自有资金支付募投项目人员费用 并以募集资金等额置换的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海赛伦生物技术股份有限公司（以下简称"公司"）于 2025 年 8 月 25 日 召开第四届董事会第八次会议，审议通过了《关于使用自有资金支付募投项目人 员费用并以募集资金等额置换的议案》，同意公司在募投项目实施期间，根据实 际需要，先行使用自有资金支付募投项目人员费用，后续定期从募集资金专户划 转等额资金至公司自有资金账户进行置换，该部分等额置换资金视同募投项目使 用资金，上述事项无需提交公司股东会审议。保荐机构方正证券承销保荐有限责 任公司对本事项出具了明确的核查意见。现将具体情况公告如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意上海赛伦生物技术股份有限公司首 次公开发行股票注册的批复》（证监许可【2022】204 号）的批准，公司获准向 社会公开发行人民币普通股 2,706 万股，每 ...

西南证券股份有限公司 关于广东松发陶瓷股份有限公司使用募集资金置换 预先投入募投项目的自筹资金的核查意见 西南证券股份有限公司（以下简称"西南证券"或"独立财务顾问"）作为 广东松发陶瓷股份有限公司（以下简称"松发股份"、"上市公司"或"公司"） 的独立财务顾问，根据《上市公司募集资金监管规则》《上海证券交易所上市公 司自律监管指引第 1 号——规范运作》等相关法律法规和规范性文件的规定，对 松发股份使用募集资金置换预先投入募投项目的自筹资金的事项进行了审慎核 查，具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意广东松发陶瓷股份有限公司发行股 份购买资产并募集配套资金注册的批复》（证监许可〔2025〕1032 号），公司向 特定对象发行人民币普通股（A 股）109,080,992 股，发行价格为人民币 36.67 元 /股，募集资金总额为人民币 3,999,999,976.64 元，扣除各项发行费用人民币 通合伙）审验并出具了中汇会验[2025]10382 号《验资报告》。 为规范公司募集资金的管理和使用，保护投资者的权益，根据中国证监会《上 市公司募集资金监管规则》《上海证券交易所 ...

Group 1 - The board meeting was held on August 20, 2025, with all 7 directors present, and the meeting complied with relevant laws and regulations [1][2] - The board approved the use of raised funds to replace self-raised funds used for project investments and issuance expenses, totaling 264,100 RMB (excluding VAT) [1][2] - The board agreed to use up to 330 million RMB of idle raised funds for cash management, focusing on low-risk, high-liquidity financial products with a maximum investment period of 12 months [2][3] Group 2 - The board approved the temporary use of up to 100 million RMB of idle raised funds to supplement working capital, limited to operations related to the main business, with a maximum usage period of 12 months [3][4] - The board agreed to use self-owned funds and bank acceptance bills to pay for project expenses, with plans to replace these with raised funds later [4][5] - The board unanimously agreed to hold the second temporary shareholders' meeting on September 8, 2025 [5]

证券代码：300539 证券简称：横河精密 公告编号：2025-040 宁波横河精密工业股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、监事会会议召开情况 （一）本次监事会会议由监事会主席胡赞文先生召集，会议通知于 2025 年 召开时间、地点、内容和方式。 （二）本次监事会于 2025 年 8 月 20 日在宁波横河精密工业股份有限公司 （以 下简称"公司"）会议室召开，本次会议采用现场和通讯相结合的出席及表决方 式。 （三）本次监事会应出席监事 3 人，实际出席监事 3 人。 （四）本次监事会由监事会主席胡赞文先生主持，董事会秘书胡建锋先生列 席了本次监事会。 具体内容详见公司同日于指定信息披露媒体《证券时报》及巨潮资讯网 （www.cninfo.com.cn）披露的《关于使用募集资金置换预先投入募投项目及已支 付发行费用的自筹资金的公告》。 表决结果：同意 3 票，反对 0 票，弃权 0 票，本议案获得通过。 （二）审议通过《关于使用部分闲置募集资金进行现金管理的议案》 经审议，监事会同意公司在不影响募集资金投资项目建设和公司正常经营的 ...

Core Viewpoint - The company intends to use its own funds and bank acceptance bills to pay for fundraising project expenses, subsequently replacing these with raised funds in an equivalent amount, which is deemed to enhance operational efficiency and ensure the smooth progress of fundraising projects [2][6][7] Fundraising Basic Information - The company issued 45,300,462 A-shares at a price of 12.98 yuan per share, raising a total of approximately 588 million yuan, with a net amount of about 583 million yuan after deducting issuance costs [2][3] Fundraising Investment Project Details - The total investment for the fundraising projects is approximately 593.56 million yuan, with about 588 million yuan planned to be invested from the raised funds [3] Reasons for Using Own Funds and Acceptance Bills - The company opted to use its own funds and bank acceptance bills for initial payments due to regulatory restrictions on salary payments from the fundraising account and the need for operational efficiency in handling taxes and other expenses [4][5] Operational Process for Fund Replacement - The company has established a detailed process for replacing its own funds with raised funds, including monthly statistics and necessary approvals to ensure compliance and proper documentation [5] Impact on Company Operations - The use of own funds and acceptance bills is expected to improve operational efficiency, enhance fund turnover, and not affect the implementation of fundraising projects or shareholder interests [5][6] Review Procedures and Opinions - Both the board of directors and the supervisory board have approved the use of own funds and acceptance bills, confirming that the process adheres to necessary regulations and does not alter the intended use of raised funds [6][7]

Core Viewpoint - The company, Ningbo Henghe Precision Industry Co., Ltd., is utilizing raised funds to replace pre-invested self-raised funds for investment projects and paid issuance expenses, in compliance with relevant regulations [2][8]. Fundraising Basic Information - The company issued 45,300,462 A-shares at a price of 12.98 RMB per share, raising a total of approximately 588 million RMB, with a net amount of about 583 million RMB after deducting issuance expenses [2][3]. Investment Project Information - The total investment for the projects funded by the raised capital is approximately 593.56 million RMB, with 588 million RMB planned to be allocated from the raised funds [3][4]. Pre-Investment and Replacement Details - The company pre-invested approximately 123.37 million RMB from self-raised funds before the raised funds were in place, which includes 123.11 million RMB for investment projects and 264,074.39 RMB for issuance expenses [4][5]. Approval Procedures and Opinions - The board of directors and the supervisory board have approved the use of raised funds to replace pre-invested self-raised funds, confirming compliance with relevant regulations and ensuring no impact on the normal progress of investment projects [7][8][9].